Home / Inspections / 1020144

FDA Inspection 1020144 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567064

The FDA completed an inspection of Regenerative Biologics, Inc. on June 14, 2017 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tallahassee, FL (United States)

Facility

Other inspections at this facility

  • 934502 (NAI Fri Jul 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 824233 (NAI Fri Mar 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734259 (NAI Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources